Orbis Biosciences and Daré Bioscience Collaborate to Advance Innovation for Reproductive Health
LENEXA, KS – March 12, 2018 – Orbis Biosciences, Inc. announced today it has granted Daré Bioscience, Inc. an exclusive option to license worldwide rights to Orbis’ long-acting contraceptive products. This agreement leverages Orbis’ StratµmTM technology to create an etonogestrel contraceptive